Hana biosciences licenses north american commercial rights...

Hana biosciences licenses north american commercial rights for zensanatm to par pharmaceutical in a $50 million deal

How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Language:
english
Journal:
Cancer Biology & Therapy
DOI:
10.4161/cbt.6.8.5016
Date:
August, 2007
File:
PDF, 390 KB
english, 2007
Conversion to is in progress
Conversion to is failed